|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ng SC and Wong SH: Colorectal cancer
screening in Asia. Br Med Bull. 105:29–42. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
DeSantis CE, Lin CC, Mariotto AB, Siegel
RL, Stein KD, Kramer JL, Alteri R, Robbins AS and Jemal A: Cancer
treatment and survivorship statistics, 2014. CA Cancer J Clin.
64:252–271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hutagalung AH and Novick PJ: Role of Rab
GTPases in membrane traffic and cell physiology. Physiol Rev.
91:119–149. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Charng WL, Yamamoto S, Jaiswal M, Bayat V,
Xiong B, Zhang K, Sandoval H, David G, Gibbs S, Lu HC, et al:
Drosophila Tempura, a novel protein prenyltransferase α subunit,
regulates notch signaling via Rab1 and Rab11. PLoS Biol.
12:e10017772014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang C, Yoo Y, Fan H, Kim E, Guan KL and
Guan JL: Regulation of Integrin β 1 recycling to lipid rafts by
Rab1a to promote cell migration. J Biol Chem. 285:29398–29405.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tanaka M, Mun S, Harada A, Ohkawa Y,
Inagaki A, Sano S, Takahashi K, Izumi Y, Osada-Oka M, Wanibuchi H,
et al: Hsc70 contributes to cancer cell survival by preventing
Rab1A degradation under stress conditions. PLoS One. 9:e967852014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Coune PG, Bensadoun JC, Aebischer P and
Schneider BL: Rab1A over-expression prevents Golgi apparatus
fragmentation and partially corrects motor deficits in an
alpha-synuclein based rat model of Parkinson's disease. J
Parkinsons Dis. 1:373–387. 2011.PubMed/NCBI
|
|
9
|
Wu G, Yussman MG, Barrett TJ, Hahn HS,
Osinska H, Hilliard GM, Wang X, Toyokawa T, Yatani A, Lynch RA, et
al: Increased myocardial Rab GTPase expression: A consequence and
cause of cardiomyopathy. Circ Res. 89:1130–1137. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu H, Qian M, Zhao B, Wu C, Maskey N, Song
H, Li D, Song J, Hua K and Fang L: Inhibition of RAB1A suppresses
epithelial-mesenchymal transition and proliferation of
triple-negative breast cancer cells. Oncol Rep. 37:1619–1626. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu BH, Li XX, Yang Y, Zhang MY, Rao HL,
Wang HY and Zheng XF: Aberrant amino acid signaling promotes growth
and metastasis of hepatocellular carcinomas through Rab1A-dependent
activation of mTORC1 by Rab1A. Oncotarget. 6:20813–20828.
2015.PubMed/NCBI
|
|
12
|
Thomas JD, Zhang YJ, Wei YH, Cho JH,
Morris LE, Wang HY and Zheng XF: Rab1A is an mTORC1 activator and a
colorectal oncogene. Cancer Cell. 26:754–769. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wullschleger S, Loewith R and Hall MN: TOR
signaling in growth and metabolism. Cell. 124:471–484. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang X, Chu Y, Wang W and Yuan W: mTORC
signaling in hematopoiesis. Int J Hematol. 103:510–518. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Laplante M and Sabatini DM: mTOR signaling
in growth control and disease. Cell. 149:274–293. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shaw RJ and Cantley LC: Ras, PI(3)K and
mTOR signalling controls tumour cell growth. Nature. 441:424–430.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Han G, Gong H, Wang Y, Guo S and Liu K:
AMPK/mTOR-mediated inhibition of survivin partly contributes to
metformin-induced apoptosis in human gastric cancer cell. Cancer
Biol Ther. 16:77–87. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Don AS and Zheng XF: Recent clinical
trials of mTOR-targeted cancer therapies. Rev Recent Clin Trials.
6:24–35. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li L, Kim E, Yuan H, Inoki K,
Goraksha-Hicks P, Schiesher RL, Neufeld TP and Guan KL: Regulation
of mTORC1 by the Rab and Arf GTPases. J Biol Chem. 285:19705–19709.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang K, Jiang L, Hu Y, Yu J, Chen H, Yao Y
and Zhu X: Short hairpin RNA- mediated gene knockdown of FOXM1
inhibits the proliferation and metastasis of human colon cancer
cells through reversal of epithelial-to-mesenchymal transformation.
J Exp Clin Cancer Res. 34:402015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shao X, Kuai X, Pang Z, Zhang L, Wu L, Xu
L and Zhou C: Correlation of Gli1 and HER2 expression in gastric
cancer: Identification of novel target. Sci Rep. 8:3972018.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhou WW, Chu YP and An GY: Significant
difference of neutrophil-lymphocyte ratio between colorectal
cancer, adenomatous polyp and healthy people. Eur Rev Med Pharmacol
Sci. 21:5386–5391. 2017.PubMed/NCBI
|
|
23
|
Zhang Z, Dong X, Yang X, Wan D, Sun L, Gu
M, Li M, Zhu Z, Wang J, Shang Z, et al: Expression and clinical
significance of absent in melanoma 2 in colorectal cancer. Biomed
Pharmacother. 94:843–849. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Polivka J Jr and Janku F: Molecular
targets for cancer therapy in the PI3K/AKT/mTOR pathway. Pharmacol
Ther. 142:164–175. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Phyu SM, Tseng CC, Fleming IN and Smith
TA: Probing the PI3K/Akt/mTor pathway using 31P-NMR spectroscopy:
Routes to glycogen synthase kinase 3. Sci Rep. 6:365442016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Satoh A, Wang Y, Malsam J, Beard MB and
Warren G: Golgin-84 is a rab1 binding partner involved in Golgi
structure. Traffic. 4:153–161. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shimada K, Uzawa K, Kato M, Endo Y, Shiiba
M, Bukawa H, Yokoe H, Seki N and Tanzawa H: Aberrant expression of
RAB1A in human tongue cancer. Br J Cancer. 92:1915–1921. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nikoshkov A, Broliden K, Attarha S,
Sviatoha V, Hellström AC, Mints M and Andersson S: Expression
pattern of the PRDX2, RAB1A, RAB1B, RAB5A and RAB25 genes in normal
and cancer cervical tissues. Int J Oncol. 46:107–112. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sun T, Wang X, He HH, Sweeney CJ, Liu SX,
Brown M, Balk S, Lee GS and Kantoff PW: MiR-221 promotes the
development of androgen independence in prostate cancer cells via
downregulation of HECTD2 and RAB1A. Oncogene. 33:2790–2800. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Abd Elmageed ZY, Yang Y, Thomas R, Ranjan
M, Mondal D, Moroz K, Fang Z, Rezk BM, Moparty K, Sikka SC, et al:
Neoplastic reprogramming of patient-derived adipose stem cells by
prostate cancer cell-associated exosomes. Stem Cells. 32:983–997.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang X, Liu F, Qin X, Huang T, Huang B,
Zhang Y and Jiang B: Expression of Rab1A is upregulated in human
lung cancer and associated with tumor size and T stage. Aging
(Albany NY). 8:2790–2798. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xu B, Huang C, Yang X, Li X, Li L and Ding
Y: Significance and prognostic role of human epidermal growth
factor receptor 2 and RAB1A expression in gastric cancer. Oncol
Lett. 15:5185–5192. 2018.PubMed/NCBI
|
|
33
|
Wang ZK, Cheng ZW, Chen SJ, Zhu XG, Gu YP,
Yang XD, Sun L, Liu WT, Zhang YJ, Yuan JF, et al: Aberrant
expression of Rab1A and its prognostic significance in human
colorectal cancer. Eur Rev Med Pharmacol Sci. 22:4509–4517.
2018.PubMed/NCBI
|
|
34
|
Kim YM, Jung CH, Seo M, Kim EK, Park JM,
Bae SS and Kim DH: mTORC1 phosphorylates UVRAG to negatively
regulate autophagosome and endosome maturation. Mol Cell.
57:207–218. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xu J, Fotouhi M and McPherson PS:
Phosphorylation of the exchange factor DENND3 by ULK in response to
starvation activates Rab12 and induces autophagy. EMBO Rep.
16:709–718. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Vaira V, Lee CW, Goel HL, Bosari S,
Languino LR and Altieri DC: Regulation of survivin expression by
IGF-1/mTOR signaling. Oncogene. 26:2678–2684. 2007. View Article : Google Scholar : PubMed/NCBI
|
